Stocks in Focus: Ola Electric, Saatvik Green Energy, and Others
The GIFT Nifty futures, which are an early indicator of the Nifty50 index stocks, were trading higher by 23 points at 25,762, indicating that the...
Author : Ali Waghbakriwala
Larsen and Toubro Subsidiary Plans to Sell Nabha Power for Rs 3,661 Crore
Larsen & Toubro Limited’s wholly owned arm, L&T Power Development Limited, has signed a securities purchase agreement (SPA) to divest Nabha Power Limited (NPL) to...
Arkade Developers Shares Gain 1% on Project in Mumbai
Shares of Arkade Developers turned green on 16 February after the company announced that it has taken a significant step in strengthening its footprint in...
Signature Global Shares Soar 6% on Entering a Rs 1,283 Crore JV
Shares of Signature Global (India) Ltd soared 6% on 16 February after the company announced that it had entered into a joint venture with RMZ,...
Ashoka Buildcon Shares Slump 3% Despite Securing Rs 410 Crore Project
Shares of Ashoka Buildcon fell more than 3% on 16 February despite the company securing a new road construction contract in the Republic of Liberia....
Religare Enterprises Shares Slumped 6% on Demerger Plan
Shares of Religare Enterprises Ltd (REL) declined 6% on 16 February after the Burman family-backed company approved a plan to demerge its financial services and...
Stocks in Focus: Garden Reach Shipbuilder, Hindustan Copper, and Others
The GIFT Nifty futures, which are an early indicator of the Nifty50 index stocks, were trading lower by 54 points at 25,465, indicating that the...
Stocks Under F&O Ban: Sammaan Capital, and Others
Under the futures and options (F&O) segment, two stocks were banned from trade on Monday, 16 February, by the National Stock Exchange (NSE). The securities...
Overnight Stock Market Movements: Key Developments
The Indian stock market benchmark indices, Sensex and Nifty 50, are likely to open lower on Monday amid mixed overnight global cues. Asian markets traded...
Natco Pharma Shares Slump 2% as the USFDA Issued 7 Observations
Shares of Natco Pharma Ltd were trading in the red and 2% lower on 13 February after the company announced that the US drug authority...